dinitrochlorobenzene has been researched along with Recrudescence in 22 studies
Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have done a double-blind, randomized, controlled study on 37 patients with transitional cell carcinoma in which levamisole was used as an immune adjuvant in addition to the standard therapy for non-invasive and invasive bladder cancer." | 9.04 | Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report. ( Baron, B; Dekernion, J; Kaufman, JJ; Skinner, DG; Smith, RB, 1978) |
| "Sixty-two patients with transitional cell carcinoma have been admitted to a double-blind randomized control study with levamisole as an immune adjuvant, in addition to standard therapy for noninvasive and invasive bladder cancer." | 9.04 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Levamisole has been shown to be easily administered and is well-tolerated, especially when compared to other immune adjuvants such as bacillus Calmette-Guerin or Corynebacterium parvum." | 6.64 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Tumor recurrence seems to be rare in those patients who are initially DNCB-positive." | 6.64 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "We have done a double-blind, randomized, controlled study on 37 patients with transitional cell carcinoma in which levamisole was used as an immune adjuvant in addition to the standard therapy for non-invasive and invasive bladder cancer." | 5.04 | Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report. ( Baron, B; Dekernion, J; Kaufman, JJ; Skinner, DG; Smith, RB, 1978) |
| "Sixty-two patients with transitional cell carcinoma have been admitted to a double-blind randomized control study with levamisole as an immune adjuvant, in addition to standard therapy for noninvasive and invasive bladder cancer." | 5.04 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Patients with malignant skin melanoma were given different kinds of immunotherapy; nonspecific immunotherapy with BCG vaccine, adaptive immunotherapy with methotrexate or phytohemagglutinin activated autolymphocytes, and also a combination of polychemotherapy with BCG." | 3.65 | [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy]. ( Iavorskiĭ, VV; Kadagidze, ZG; Kupin, VI; Malaev, SG; Trapeznikov, NN, 1977) |
| "Levamisole has been shown to be easily administered and is well-tolerated, especially when compared to other immune adjuvants such as bacillus Calmette-Guerin or Corynebacterium parvum." | 2.64 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Tumor recurrence seems to be rare in those patients who are initially DNCB-positive." | 2.64 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Of these 55 patients, 25 (45." | 1.27 | Topical immunotherapy of alopecia areata. A follow-up study. ( Cainelli, T; Foiadelli, L; Rossi, A; Valsecchi, R, 1986) |
| "Patients with mucosal squamous cell carcinoma of the head and neck generally have suppressed T cell function, and this suppression tends to be more pronounced with progression of disease." | 1.26 | Immunologic evaluation and prognosis in patients with head and neck cancer. ( Hilal, EY; Middleman, P; Oettgen, HF; Pinsky, CM; Strong, EW; Wanebo, HJ, 1977) |
| "After removal of the primary tumor, recurrences are noted only after a relatively long interval, infiltration of the tumor into bladder muscle being hindered by immunocyte activity." | 1.26 | [Influence of T-lymphocytes in bladder cancer on appearance and infiltration of recurrences (author's transl)]. ( Stöber, U, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (86.36) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goihman-Yahr, M | 1 |
| Georgala, S | 1 |
| Avgerinou, G | 1 |
| Perdikari, P | 1 |
| Vareltzidis, A | 1 |
| Herbert-Zebrowska, H | 1 |
| Wanebo, HJ | 4 |
| Rao, B | 2 |
| Attiyeh, F | 1 |
| Pinsky, C | 2 |
| Middleman, P | 2 |
| Stearns, M | 2 |
| Claudy, AL | 1 |
| Roche, H | 1 |
| Gogue, Y | 1 |
| Taylor, JR | 1 |
| Schmieder, GJ | 1 |
| Shimizu, T | 1 |
| Tie, C | 1 |
| Streilein, JW | 1 |
| Yoshizawa, Y | 1 |
| Matsui, H | 1 |
| Izaki, S | 1 |
| Kitamura, K | 1 |
| Maibach, HI | 1 |
| Bertino, JR | 1 |
| Boston, B | 1 |
| Capizzi, RL | 1 |
| Breuillard, F | 1 |
| Szapiro, E | 1 |
| Hilal, EY | 2 |
| Pinsky, CM | 2 |
| Strong, EW | 2 |
| Oettgen, HF | 3 |
| Stöber, U | 1 |
| Smith, RB | 2 |
| Dekernion, J | 2 |
| Baron, B | 1 |
| Skinner, DG | 2 |
| Kaufman, JJ | 2 |
| Mike, V | 1 |
| Hirshaut, Y | 1 |
| Lincoln, B | 1 |
| Olivari, AJ | 1 |
| Glait, HM | 1 |
| Guardo, A | 1 |
| Califano, L | 1 |
| Pradier, R | 1 |
| Meyers, S | 1 |
| Sachar, DB | 1 |
| Taub, RN | 1 |
| Janowitz, HD | 1 |
| El-Domeiri, AA | 1 |
| Trapeznikov, NN | 1 |
| Iavorskiĭ, VV | 1 |
| Kadagidze, ZG | 1 |
| Malaev, SG | 1 |
| Kupin, VI | 1 |
| Valsecchi, R | 1 |
| Cainelli, T | 1 |
| Foiadelli, L | 1 |
| Rossi, A | 1 |
| Jackson, WB | 1 |
| Beraja, R | 1 |
| Codère, F | 1 |
| Advani, SH | 1 |
| Gulwani, B | 1 |
| Ghogale, SG | 1 |
| Shetye, MR | 1 |
| Gangal, SG | 1 |
6 trials available for dinitrochlorobenzene and Recrudescence
| Article | Year |
|---|---|
Combined immunotherapy of recalcitrant warts.
Topics: Administration, Cutaneous; Aminoquinolines; Dinitrochlorobenzene; Drug Administration Schedule; Drug | 2006 |
Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy.
Topics: Administration, Topical; Adolescent; Adult; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Humans | 2000 |
Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
Topics: Aged; Antigens, Neoplasm; Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as To | 1978 |
Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
Topics: Carcinoma, Squamous Cell; Central Nervous System; Clinical Trials as Topic; Digestive System; Dinitr | 1978 |
Preliminary report of the use of levamisole in the treatment of bladder cancer.
Topics: Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as Topic; Dinitrochlorobenzene; | 1978 |
Levamisole in squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Dinitrochlorobenzene; Female; Head | 1979 |
16 other studies available for dinitrochlorobenzene and Recrudescence
| Article | Year |
|---|---|
Parameters of cell-mediated immunity in recurrent herpes simplex.
Topics: Adult; Cell Migration Inhibition; Dermatitis, Contact; Dinitrochlorobenzene; Female; Herpes Genitali | 1983 |
[Dinitrochlorobenzene (DNCB) skin test in children with inflammatory diseases of the respiratory tract and tuberculosis].
Topics: Adolescent; Bronchitis; Child; Child, Preschool; Chronic Disease; Dinitrochlorobenzene; Humans; Immu | 1983 |
Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters.
Topics: Carcinoembryonic Antigen; Colonic Neoplasms; Dinitrochlorobenzene; Humans; Immunity; Leukocyte Count | 1980 |
[Immunotherapy of multiple recurring warts. Reassessment of the use of dinitrochlorobenzene (author's transl)].
Topics: Adolescent; Adult; Child; Dinitrochlorobenzene; Hand Dermatoses; Humans; Hypersensitivity, Delayed; | 1980 |
Interrelationship between ultraviolet light and recurrent herpes simplex infections in man.
Topics: Adult; Dermatitis, Contact; Dinitrochlorobenzene; Dose-Response Relationship, Drug; Dose-Response Re | 1994 |
The role of chemotherapy in the management of cancer of the head and neck: a review.
Topics: Bleomycin; Dinitrochlorobenzene; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Head and Neck | 1975 |
Dinitrochlorobenzene in alopecia areata.
Topics: Acetone; Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Dinitrochlorobenzene; F | 1978 |
Immunologic evaluation and prognosis in patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Concanavalin A; Dinitrochlorobenzene; Female; Head and Neck Neoplasms; Hum | 1977 |
[Influence of T-lymphocytes in bladder cancer on appearance and infiltration of recurrences (author's transl)].
Topics: Dinitrochlorobenzene; Female; Humans; Recurrence; Skin Tests; T-Lymphocytes; Urinary Bladder Neoplas | 1978 |
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies.
Topics: Colitis, Ulcerative; Crohn Disease; Dinitrochlorobenzene; Female; Humans; Immunity, Cellular; Male; | 1978 |
Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum.
Topics: Adenocarcinoma; Age Factors; Aged; Antigens; Colonic Diseases; Colonic Neoplasms; Dinitrochlorobenze | 1977 |
Delayed hypersensitivity reaction: its relation to tumor spread and prognosis.
Topics: Antigens, Neoplasm; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Neo | 1977 |
[Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Topics: Antigen-Antibody Reactions; BCG Vaccine; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Im | 1977 |
Topical immunotherapy of alopecia areata. A follow-up study.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Dinitrochlorobenze | 1986 |
Laser therapy of conjunctival papillomas.
Topics: Adult; Conjunctival Neoplasms; Cryosurgery; Dinitrochlorobenzene; Humans; Idoxuridine; Immunotherapy | 1987 |
Effect of administration of BCG, levamisole and irradiated leukemic cells on immune status and remission status in chronic myelogenous leukemia.
Topics: Adult; Antigens, Neoplasm; BCG Vaccine; Dinitrochlorobenzene; Humans; Immunity; Leukemia, Myeloid; L | 1985 |